Editorial: Study on immune mechanism and immune intervention in connective tissue diseases.
作者信息
Murdaca Giuseppe, Su Wenru, Lin Zhiming, Adamichou Christina, Leone Patrizia, Sikora Mariusz, Paladin Francesca
机构信息
Department of Internal Medicine, University of Genova, Viale Benedetto XV, Genoa, Italy.
Allergology and Clinical Immunology Unit, San Bartolomeo Hospital, Sarzana, Italy.
出版信息
Front Med (Lausanne). 2025 Jul 3;12:1610785. doi: 10.3389/fmed.2025.1610785. eCollection 2025.
Abstract
摘要
相似文献
1
Editorial: Study on immune mechanism and immune intervention in connective tissue diseases.社论：结缔组织病的免疫机制及免疫干预研究
Front Med (Lausanne). 2025 Jul 3;12:1610785. doi: 10.3389/fmed.2025.1610785. eCollection 2025.
2
Cyclophosphamide for connective tissue disease-associated interstitial lung disease.环磷酰胺用于治疗结缔组织病相关的间质性肺疾病。
Cochrane Database Syst Rev. 2018 Jan 3;1(1):CD010908. doi: 10.1002/14651858.CD010908.pub2.
3
Safety of live vaccinations on immunosuppressive therapy in patients with immune-mediated inflammatory diseases, solid organ transplantation or after bone-marrow transplantation - A systematic review of randomized trials, observational studies and case reports.免疫介导性炎症疾病、实体器官移植或骨髓移植患者接受免疫抑制治疗时进行活疫苗接种的安全性——对随机试验、观察性研究和病例报告的系统评价
Vaccine. 2017 Mar 1;35(9):1216-1226. doi: 10.1016/j.vaccine.2017.01.048. Epub 2017 Feb 3.
4
The Multifaceted Role of the IL-2 Cytokine Family in Melanoma: Mechanisms, Therapeutic Implications, and Immune Modulation.白细胞介素-2细胞因子家族在黑色素瘤中的多方面作用：机制、治疗意义及免疫调节
J Immunol Res. 2025 Jul 2;2025:8890939. doi: 10.1155/jimr/8890939. eCollection 2025.
5
The intervention of macrophages in progressive fibrosis characterizing systemic sclerosis: A systematic review.巨噬细胞在系统性硬化症进行性纤维化中的干预作用：系统评价。
Autoimmun Rev. 2024 Oct;23(10):103637. doi: 10.1016/j.autrev.2024.103637. Epub 2024 Sep 8.
6
Connective tissue disease-associated interstitial lung disease: an approach to treatment amidst an expanding evidence base.结缔组织病相关间质性肺疾病：在不断扩充的证据基础上的治疗方法
Intern Med J. 2025 Jun;55(6):885-894. doi: 10.1111/imj.70026. Epub 2025 Mar 7.
7
Oncolytic reovirus enhances the effect of CEA immunotherapy when combined with PD1-PDL1 inhibitor in a colorectal cancer model.在结直肠癌模型中，溶瘤呼肠孤病毒与PD1-PDL1抑制剂联合使用时可增强CEA免疫疗法的效果。
Immunotherapy. 2025 Apr;17(6):425-435. doi: 10.1080/1750743X.2025.2501926. Epub 2025 May 12.
8
Role of innate immunity in tumor microenvironment of HPV-associated anal cancer: The hypothetical beneficial role of γδ T cells.先天免疫在人乳头瘤病毒相关肛门癌肿瘤微环境中的作用：γδ T细胞的假定有益作用。
Crit Rev Oncol Hematol. 2025 Aug;212:104771. doi: 10.1016/j.critrevonc.2025.104771. Epub 2025 May 22.
9
Prediction Model for Immunotherapy Efficacy in Hepatocellular Carcinoma Based on Alternative Splicing Sequencing Data.基于剪接测序数据的肝细胞癌免疫治疗疗效预测模型。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241265962. doi: 10.1177/15330338241265962.
10
Nutrient deprivation and hypoxia alter T cell immune checkpoint expression: potential impact for immunotherapy.营养剥夺和缺氧改变 T 细胞免疫检查点表达：免疫治疗的潜在影响。
J Cancer Res Clin Oncol. 2023 Jul;149(8):5377-5395. doi: 10.1007/s00432-022-04440-0. Epub 2022 Nov 29.
本文引用的文献
1
Cell-Based Therapy and Genome Editing as Emerging Therapeutic Approaches to Treat Rheumatoid Arthritis.基于细胞的治疗和基因组编辑作为新兴的治疗类风湿关节炎的方法。
Cells. 2024 Jul 30;13(15):1282. doi: 10.3390/cells13151282.
2
Anti-SMN autoantibodies in mixed connective tissue disease are associated with a severe systemic sclerosis phenotype.混合性结缔组织病中的抗-SMN 自身抗体与严重的系统性硬化症表型相关。
RMD Open. 2023 Oct;9(4). doi: 10.1136/rmdopen-2023-003431.
3
Clinical Significance of Different Profiles of anti-Ro Antibodies in Connective Tissue Diseases.抗 Ro 抗体不同谱在结缔组织病中的临床意义。
J Immunol Res. 2023 Jan 25;2023:9195157. doi: 10.1155/2023/9195157. eCollection 2023.
4
Multiparametric autoantibody analysis: a new paradigm for the diagnosis of connective tissue diseases.多参数自身抗体分析：结缔组织疾病诊断的新模式。
Arthritis Res Ther. 2022 Dec 23;24(1):278. doi: 10.1186/s13075-022-02980-x.
5
VDR Polymorphisms in Autoimmune Connective Tissue Diseases: Focus on Italian Population.维生素 D 受体多态性与自身免疫性结缔组织病：关注意大利人群。
J Immunol Res. 2021 Dec 23;2021:5812136. doi: 10.1155/2021/5812136. eCollection 2021.
6
B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial.奥滨尤妥珠单抗治疗增生性狼疮肾炎的 B 细胞耗竭：一项随机、双盲、安慰剂对照试验。
Ann Rheum Dis. 2022 Jan;81(1):100-107. doi: 10.1136/annrheumdis-2021-220920. Epub 2021 Oct 6.
7
[Targeted therapies including monoclonal antibodies for connective tissue diseases].
Nihon Rinsho. 2009 Mar;67(3):588-92.
Zotero 插件